Physician

Paul Vernon Tuttle, D.O.

According to 2025 Medicare claims, Paul Tuttle, D.O. (NPI: 1023243805) practices rheumatology in the Green Bay, WI market, with the plurality of this provider's patient population coming from Brown, WI. This provider's primary affiliated billing organization is ORTHOPEDIC & SPORTS MEDICINE SPECIALISTS OF GREEN BAY, SC (NPI: 1760670145; TIN: 261132759) and primary practice location at 54311-6213. Tuttle is affiliated with the OSF Healthcare System (ACO ID: A3289), AdvantagePoint Health Alliance - Great Lakes, LLC (ACO ID: A4652), Bellin Health Partners, Inc. (ACO ID: A4977), THEDACARE ACO (ACO ID: A4988), and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Tuttle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 404 traditional Medicare patients, billed 72,512 HCPCS/CPT codes, and received $1,325,978 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 5,329 prescription claims across 748 beneficiaries totaling $3,689,139 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 36 records totaling $678. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $387,996 to $3,689,139. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	81	1,038	$36,752
2017	300	30,386	$717,939
2018	388	57,088	$1,199,469
2019	400	88,578	$1,543,337
2020	345	71,591	$1,115,686
2021	432	74,049	$1,293,756
2022	401	56,230	$905,042
2023	400	67,409	$1,119,279
2024	404	72,512	$1,325,978

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	130	623	$387,996
2016	173	655	$273,433
2017	352	1,713	$861,301
2018	413	2,568	$1,272,437
2019	439	2,854	$1,782,283
2020	419	2,981	$2,410,480
2021	529	3,618	$2,941,662
2022	585	4,186	$3,307,588
2023	649	4,571	$4,427,311
2024	748	5,329	$3,689,139

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	100	243	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	255	423	$88
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	87	251	$47
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	169	239	$12
J7050	Infusion, normal saline solution, 250 cc	177	512	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	125	3,844	$1,573,079
Enbrel Mini	Etanercept	57	1,596	$418,077
Cosentyx Sensoready (2 Pens)	Secukinumab	28	1,176	$306,776
Rinvoq	Upadacitinib	40	1,200	$250,868
Orencia Clickject	Abatacept	23	756	$150,090

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$678	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul Vernon Tuttle, D.O.?

Tedicare shows public-source Medicare data for Paul Vernon Tuttle, D.O. (NPI 1023243805), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul Vernon Tuttle, D.O. have ACO affiliation data?

Paul Vernon Tuttle, D.O. is shown with ACO affiliation data for OSF Healthcare System (MSSP, ACO ID A3289), AdvantagePoint Health Alliance - Great Lakes, LLC (MSSP, ACO ID A4652), Bellin Health Partners, Inc. (MSSP, ACO ID A4977), THEDACARE ACO (MSSP, ACO ID A4988), and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Paul Vernon Tuttle, D.O.?

Paul Vernon Tuttle, D.O. is linked to ORTHOPEDIC & SPORTS MEDICINE SPECIALISTS OF GREEN BAY, SC (billing NPI 1760670145) in the available physician profile data.

Does Paul Vernon Tuttle, D.O. have Open Payments data?

Paul Vernon Tuttle, D.O. has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.